Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,216
NCT00747214
A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2004
Completion: Nov 30, 2006
NCT00506298
Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
Start: Jul 31, 2007
Completion: May 31, 2009
NCT00521989
CRx-102 Osteoarthritis Multicenter Evaluation Trial
Start: Aug 31, 2007
Completion: Jul 31, 2009
NCT00544687
Phase I Study of Topical CRx-191 in Normal Healthy Volunteers
Phase: Phase 1
Start: Sep 30, 2007
Completion: Nov 30, 2007
NCT00551707
Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
Start: Oct 31, 2007
Completion: Jan 31, 2009
NCT00557739
Study of CRx-191 to Assess Activity in Plaque Psoriasis
Start: Nov 30, 2007
Completion: Jan 31, 2008
NCT00721331
A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers
Start: Jul 31, 2008
Completion: Sep 30, 2008
NCT00796211
A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis
Start: Nov 30, 2008
NCT01369745
A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
Start: Jun 30, 2011
Completion: Sep 30, 2012
NCT01612377
Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis
Start: Mar 31, 2012
Completion: Sep 30, 2013
NCT01655849
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
Start: Aug 31, 2012
Completion: Nov 30, 2013
NCT01757873
Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
Start: Dec 31, 2012